Hyperprogression-Immunotherapy-Related Phenomenon vs Intrinsic Natural History of Cancer

JAMA Oncol. 2019 May 1;5(5):743. doi: 10.1001/jamaoncol.2019.0130.
No abstract available

Publication types

  • Comment

MeSH terms

  • B7-H1 Antigen
  • Carcinoma, Non-Small-Cell Lung*
  • Humans
  • Immunotherapy
  • Lung Neoplasms*
  • Neoplasms*
  • Programmed Cell Death 1 Receptor

Substances

  • B7-H1 Antigen
  • Programmed Cell Death 1 Receptor